Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ucommune International (UK) Cash & Equivalents (2018 - 2025)

Ucommune International has reported Cash & Equivalents over the past 8 years, most recently at $5.1 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 45.39% year-over-year to $5.1 million; the TTM value through Dec 2025 reached $5.1 million, up 45.39%, while the annual FY2025 figure was $13.0 million, 1137.1% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $5.1 million at Ucommune International, down from $8.7 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $47.4 million in Q2 2021 and troughed at $92517.5 in Q4 2022.
  • A 5-year average of $13.2 million and a median of $7.9 million in 2023 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: tumbled 99.25% in 2021 and later skyrocketed 8049.72% in 2023.
  • Year by year, Cash & Equivalents stood at $200829.9 in 2021, then tumbled by 53.93% to $92517.5 in 2022, then skyrocketed by 8049.72% to $7.5 million in 2023, then crashed by 53.62% to $3.5 million in 2024, then surged by 45.39% to $5.1 million in 2025.
  • Business Quant data shows Cash & Equivalents for UK at $5.1 million in Q4 2025, $8.7 million in Q2 2025, and $3.5 million in Q4 2024.